Goldman Sachs lifts Viking Holdings stock price target on strong 2027 bookings
Corroborated by 3 sources from 3 publishers
TL;DR
Goldman Sachs BDC (GSBD) is a BDC run by one of the most recognizable names in the financial world Goldman Sachs lowers Regenxbio stock price target on regulatory uncertainty.
Sources
1
Seeking Alpha Market News
https://seekingalpha.com/article/4904448-deep-dive-into-goldman-sachs-bdc-portfolio-evaluation-performance-and-investment-value?source=feed_all_articles
2
Seeking Alpha Market News
https://seekingalpha.com/article/4905040-goldman-sachs-bdc-stock-collapsing-dividend-coverage-rating-downgrade?source=feed_all_articles
3
Investing.com News
https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-regenxbio-stock-price-target-on-regulatory-uncertainty-93CH-4691367
4
Investing.com News
https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-viking-holdings-stock-price-target-on-strong-2027-bookings-93CH-4691369
5
Investing.com News
https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-kodiak-gas-services-stock-price-target-to-88-on-power-growth-93CH-4691370
6
Investing.com News
https://www.investing.com/news/analyst-ratings/goldman-sachs-upgrades-oric-pharmaceuticals-stock-rating-to-buy-93CH-4691469
7
Bloomberg Markets
https://www.bloomberg.com/news/articles/2026-05-15/goldman-floats-risk-transfer-deal-tied-to-private-market-loans